Skip to content
Immatics

Immatics

Biotech·Germany·Active·20yr hold
Entry
2006
Hold
20yr
Status
Active

Who owns Immatics?

Immatics is currently owned by dievini Hopp BioTech holding through dievini Hopp BioTech holding (Evergreen Balance Sheet) (2005 vintage), since 2006. Across its history, Immatics has been through 4 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-03

dievini Hopp BioTech holding
Most recent investor
dievini Hopp BioTech holding
dievini Hopp BioTech holding (Evergreen Balance Sheet) · 2005 · Evergreen
5 ownership periods · full history below

Key facts

HQGermany
SectorBiotech
StatusActive
Key takeaways
  • ·Co-held by dievini Hopp BioTech holding and Athos since 2006.
  • ·Average hold across 3 realized cycles: 12 years.
  • ·4 distinct PE sponsors across ownership cycles.

Ownership history

5 ownership periods · co-invest detected

Active
Co-held by dievini Hopp BioTech holding and Athos since 2006.
Co-invest · 5 holders · 2004 · present
Wellington Partners
2004 · 2020(16yr) · Wellington Partners Life Sciences · 1998 · VC
IPO
MOIC
dievini Hopp BioTech holding
2006 · present(20yr) · dievini Hopp BioTech holding (Evergreen Balance Sheet) · 2005 · Evergreen
MIG Capital
MIG CapitalExited 2020
2010 · 2020(10yr) · MIG Fonds 8 · 2009 · Evergreen
IPO · to
MOIC
MIG Capital
MIG CapitalExited 2020
2010 · 2020(10yr) · MIG Fonds 5 · 2007 · Evergreen
IPO
MOIC
Athos
AthosActive
2020 · present(6yr) · Athos Evergreen Life Sciences · 2001 · Evergreen
Track Immatics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Immatics?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Immatics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue